Fenwick Represents Science Exchange in Acquisition by Waud Capital Partners

Fenwick represented Science Exchange, a provider of life sciences procurement and supplier management SaaS solution, in its acquisition by Waud Capital Partners, a growth-oriented middle-market private equity firm specializing in the software & technology and healthcare sectors.

This acquisition marks a significant milestone in Science Exchange’s journey and will compound the company’s impressive performance, growth trajectory and software capabilities. More information can be obtained from Science Exchange’s announcement.

Fenwick has served as outside counsel to Science Exchange since 2014, led by corporate partner Michael Esquivel. The Fenwick team included corporate partners Ethan Skerry, Michael Esquivel and Will Black and associates Brendan Montgomery, Brandon Ho, Ankeet Ball and Max Krinsky; technology transactions partner Joseph Schenck and associates Peter Hart and Taylor Muentener; executive compensation and employee benefits partner Shawn Lampron and associates Christophe Delrieu and Melita Chan; tax partner William Skinner and associate Einav Axler; healthcare regulatory partner Jennifer Yoo; and privacy and cybersecurity counsel Melanie Jolson.